It’s the law: Oba­ma signs wide­ly pop­u­lar 21st Cen­tu­ry Cures Act

In the end, the 21st Cen­tu­ry Cures Act looked like an old-time bill, laden with ex­tras for can­cer re­search, an­tibi­otics, the opi­oid epi­dem­ic and even Alzheimer’s, which has man­aged to re­sist just about every­thing thrown at it so far. It even had the kind of bi­par­ti­san sup­port that you don’t see much these days in Wash­ing­ton D.C.

Vice Pres­i­dent Joe Biden was there to sa­vor the mo­ment as Pres­i­dent Oba­ma inked the near­ly 1,000-page ini­tia­tive, which helps cap­ture more mon­ey for can­cer drug re­search — his last big ini­tia­tive. And the bio­phar­ma in­dus­try reps, along with some 1,300 lob­by­ists, were hap­py to see promis­es of short­er, swifter drug ap­provals with new FDA fund­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.